CIK 0000872912 · Non-accelerated filer<br>Smaller reporting company
DELCATH SYSTEMS, INC.
Sign in to watch- Ticker
- DCTH
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061245881
- Phone
- (518) 743-8892
- Business address
- 566 QUEENSBURY AVENUE, QUEENSBURY, NY, 12804
- Former names
- DELCATH SYSTEMS, INC., DELCATH SYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $488,508
- in 1 filing
Net −$488,508. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-18 | SALAMON STEVEN A J Director | Option exercise | +619,946 | $6,199.46 | $3.8B | 2,732,586 |
| 2024-04-18 | Rosalind Advisors, Inc. Director | Option exercise | +619,946 | $0.01 | $6K | 2,763,468 |
| 2024-04-18 | Rosalind Advisors, Inc. Director | Conversion | +991,615 | 2,763,468 | ||
| 2024-04-18 | Rosalind Advisors, Inc. Director | Option exercise | +619,946 | $6,199.46 | $3.8B | 2,763,468 |
| 2024-04-18 | Rosalind Advisors, Inc. Director | Conversion | +991,615 | 2,763,468 | ||
| 2024-03-19 | Aharon Gil Director | Purchase | +26,882 | $3.72 | $100K | 1,069,710 |
| 2024-03-19 | SALAMON STEVEN A J Director | Purchase | +26,882 | $3.72 | $100K | 1,121,025 |
| 2024-03-19 | Rosalind Advisors, Inc. Director | Purchase · Pre-funded Warrants | +619,946 | $3.71 | $2.3M | 836,133 |
| 2024-03-19 | Vukovic Vojo CHIEF MEDICAL OFFICER | Grant or award | +26,882 | $3.72 | $100K | 126,882 |
| 2024-03-19 | MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Grant or award | +40,323 | $3.72 | $150K | 302,668 |
| 2024-03-19 | Pennell Sandra SVP OF FINANCE, PFO AND PAO | Grant or award | +26,881 | $3.72 | $100K | 61,052 |
| 2024-03-19 | Muir Kevin GM INTERVENTIONAL ONCOLOGY | Grant or award | +13,441 | $3.72 | $50K | 18,582 |
| 2024-03-19 | Hoffman David L. GEN'L COUNSEL, CCO & SECY | Grant or award | +20,161 | $3.72 | $75K | 74,330 |
| 2024-03-18 | Rook Martha S. CHIEF OPERATING OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2024-02-12 | Vukovic Vojo CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +100,500 | 100,500 | ||
| 2024-02-12 | MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +301,500 | 301,500 | ||
| 2024-02-12 | Muir Kevin VP COMMERCIAL OPERATIONS | Grant or award · Stock Option (Right to Buy) | +100,500 | 100,500 | ||
| 2024-02-12 | Pennell Sandra SVP OF FINANCE, PFO AND PAO | Grant or award · Stock Option (Right to Buy) | +100,500 | 100,500 | ||
| 2024-02-12 | Hoffman David L. GEN'L COUNSEL, CCO & SECY | Grant or award · Stock Option (Right to Buy) | +100,500 | 100,500 | ||
| 2023-12-12 | Vukovic Vojo Chief Medical Officer | Purchase | +40,000 | $3.00 | $120K | 100,000 |
Page 5 of 7 · 138 trades